Trial · NCT00772941
Results by group26
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 26
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Risk Factors for the Frequency of Treatment Related Adverse Events - Gender. | Male | 377 | participants | ||
| Risk Factors for the Frequency of Treatment Related Adverse Events - Gender. | Female | 336 | participants | ||
| Risk Factors for the Frequency of Treatment Related Adverse Events - Age. | <65 Years | 571 | participants | ||
| Risk Factors for the Frequency of Treatment Related Adverse Events - Age. | >=65 Years | 142 | participants | ||
| Risk Factors for the Frequency of Treatment Related Adverse Events - Chronic Obstructive Pulmonary Disease as a Complication. | Varenicline - With Chronic Obstructive Pulmonary Disease | 23 | participants | ||
| Risk Factors for the Frequency of Treatment Related Adverse Events - Chronic Obstructive Pulmonary Disease as a Complication. | Varenicline - Without Chronic Obstructive Pulmonary Disease | 690 | participants | ||
| Risk Factors for the Frequency of Treatment Related Adverse Events - Concomitant Drugs. | Varenicline - With Concomitant Drugs | 289 | participants | ||
| Risk Factors for the Frequency of Treatment Related Adverse Events - Concomitant Drugs. | Varenicline - Without Concomitant Drugs | 424 | participants | ||
| Risk Factors for the Frequency of Treatment Related Adverse Events - Concomitant Therapies. | Varenicline - With Concomitant Therapies | 45 | participants | ||
| Risk Factors for the Frequency of Treatment Related Adverse Events - Concomitant Therapies. | Varenicline - Without Concomitant Therapies | 668 | participants | ||
| Risk Factors for the Frequency of Treatment Related Adverse Events - Weight at Baseline. | <40 kg at Baseline | 6 | participants | ||
| Risk Factors for the Frequency of Treatment Related Adverse Events - Weight at Baseline. | >=40 kg and <50 kg at Baseline | 98 | participants | ||
| Risk Factors for the Frequency of Treatment Related Adverse Events - Weight at Baseline. | >=50 kg and <60 kg at Baseline | 135 | participants | ||
| Risk Factors for the Frequency of Treatment Related Adverse Events - Weight at Baseline. | >=60 kg and <70 kg at Baseline | 110 | participants | ||
| Risk Factors for the Frequency of Treatment Related Adverse Events - Weight at Baseline. | >=70 kg and <80 kg at Baseline | 61 | participants | ||
| Risk Factors for the Frequency of Treatment Related Adverse Events - Weight at Baseline. | >= 80 kg at Baseline | 31 | participants | ||
| Risk Factors for the Proportion of Responders - Tobacco Consumption Per Day. | <=20 Cigarettes Per Day | 1299 | participants | ||
| Risk Factors for the Proportion of Responders - Tobacco Consumption Per Day. | >=21 and <=40 Cigarettes Per Day | 817 | participants | ||
| Risk Factors for the Proportion of Responders - Tobacco Consumption Per Day. | >=41 Cigarettes Per Day | 66 | participants | ||
| Risk Factors for the Proportion of Responders - Prolonged Administration After 12 Weeks. | Administration Prolonged After 12 Weeks | 39 | participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00772941/results